bringing you the latest and original global medtech industry dynamics
news about in-vitro diagnostics
a molecular diagnostic test that detects and differentiates four of the most prevalent respiratory viruses that can exhibit similar clinical symptoms: severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza A (flu A), influenza B (flu B) and respiratory syncytial virus (RSV)
Read More
offering intuitive interfaces and multi-analyzer automation connectivity to eliminate workflow roadblocks and achieve the fast throughput
Read More
Devyser’s RHD product is used by diagnostic laboratories for the non-invasive determination of the RHD status of fetuses from maternal blood samples
Read More
Increasing localized access can provide faster results for patients while potentially improving patient outcomes
Read More
Scopio Labs has granted to Siemens Healthineers global rights to distribute the Scopio X100 and Scopio X100HT, digital solutions that offer full-field imaging and an AI-powered Decision Support System with remote viewing capabilities
Read More
Marks Important Milestone in Commercialization of Blood Screening Tool that is Intended to be used Alongside Current Breast Cancer Screening Methods
Read More
Bladder EpiCheck is the first urine biomarker methylation test of its kind to be FDA cleared for NMIBC surveillance
Read More
xT CDx is a qualitative Next Generation Sequencing (NGS)-based in vitro diagnostic device intended for use in the detection of substitutions (single nucleotide variants (SNVs) and multi-nucleotide variants (MNVs)) and insertion and deletion alterations (INDELs) in 648 genes
Read More
Adding Sensitive Liquid Biopsy Technology for Improving Personalized Cancer Care to Oncology Portfolio
Read More
New funding will be used to accelerate development of first-of-its-kind infectious disease diagnostic platform that will deliver rapid antibiotic treatment guidance
Read More
English (UK) 
简体中文 
Deutsch 
Français 
Español 
Português